Gaston-Dreyfus Remi has bought 3,102,878 shares of Bionik Laboratories Corp. [BNKL] at $0.60 a share.
Bionik Laboratories Corp. [BNKL] disclosed in an SEC Form 4 submission Tuesday, June 13, 2023 that the deal increased Gaston-Dreyfus Remi's holding in the company to 4,917,749.
Bionik Laboratories Corp. [BNKL] is a Orthopedic, Prosthetic & Surgical Appliances & Supplies company based in Delaware.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.